WEDNESDAY, May 7 (HealthDay News) -- A new class of weight-loss drugs that suppresses appetite by blocking cannabinoid receptors in the brain should be used with caution in children, U.S. scientists report.
WEDNESDAY, March 12 (HealthDay News) -- The weight-loss drug rimonabant has been associated with troubling psychiatric side effects, and now researchers think they have discovered why.